{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:10:47Z","timestamp":1778170247000,"version":"3.51.4"},"reference-count":50,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"unspecified","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2026,4,2]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate associations between cardiometabolic comorbidities and clinical characteristics, prescription patterns and retention of first biologic\/targeted synthetic disease-modifying anti-rheumatic drug (b\/tsDMARD) in patients with psoriatic arthritis (PsA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with PsA initiating a first b\/tsDMARD treatment in 2015 or later were identified in eight European rheumatology registries. Patients with information on five cardiometabolic comorbidities (obesity, dyslipidaemia, diabetes, hypertension, ischaemic heart disease) at treatment start (baseline) were included. All analyses were conducted according to patients\u2019 comorbidity burden (count: 0\/1\/\u22652) and status (presence\/absence of each comorbidity). Patient characteristics and prescription patterns were described. Twelve-month treatment retention rates were estimated and compared using Kaplan-Meier plots, log-rank tests and multivariable Cox regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 5299 patients, 36% had at least one cardiometabolic comorbidity. Patients with comorbidity were older, had higher disease activity and more disability. Regardless of comorbidity, most patients were prescribed a tumour necrosis factor inhibitor (76%). The use of interleukin-17 inhibitors increased with comorbidity burden (0\/1\/\u22652 comorbidities: 13%\/18%\/19%), whereas Janus kinase inhibitor use declined (2.3%\/1.6%\/0.8%). Retention rates were marginally lower with higher comorbidity burden (80%\/76%\/78%) (log-rank, p=0.036) and obesity (absent 79% vs present 77%) (log-rank, p=0.04). The risk of treatment withdrawal was only marginally higher in patients with higher comorbidity burden (one comorbidity: HR 1.19; 95% CI 1.02 to 1.40; \u22652 comorbidities: HR 1.18; 0.98 to 1.42).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with cardiometabolic comorbidities had higher disease activity at treatment initiation of the first b\/tsDMARD. Prescription patterns varied with comorbidity burden. Cardiometabolic comorbidity burden, especially obesity, was associated with marginally lower treatment retention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2025-006477","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:15:20Z","timestamp":1778166920000},"page":"e006477","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b\/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7675-4844","authenticated-orcid":false,"given":"Zohra Faizy","family":"Ahmadzay","sequence":"first","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-6831","authenticated-orcid":false,"given":"Lykke Midtb\u00f8ll","family":"\u00d8rnbjerg","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-467X","authenticated-orcid":false,"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4232-6079","authenticated-orcid":false,"given":"Kasper Yde","family":"Jensen","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6533-6336","authenticated-orcid":false,"given":"Jacob Brauner","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jette","family":"Heberg","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Gitte","family":"Loft","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and DANBIO, Aarhus University Hospital, Aarhus, Denmark"},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0103-2840","authenticated-orcid":false,"given":"Brigitte","family":"Michelsen","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"},{"name":"Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway"},{"name":"Research Unit, S\u00f8rlandet Hospital, Kristiansand, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0016-7591","authenticated-orcid":false,"given":"Gareth T","family":"Jones","sequence":"additional","affiliation":[{"name":"Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2251-3435","authenticated-orcid":false,"given":"Pasoon","family":"Hellamand","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Free University of Amsterdam, Amsterdam University Medical Centres, Amsterdam, The Netherlands"},{"name":"Amsterdam UMC, Amsterdam Rheumatology and Immunology Center (ARC), Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-0630","authenticated-orcid":false,"given":"Signe","family":"M\u00f8ller-Bisgaard","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"},{"name":"Reumaklinik Roskilde, Rheumatology Specialist Practice, Roskilde, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Shoae Kazemi","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parham","family":"Karimi Reikandeh","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"},{"name":"ParHub RnD ApS, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Z\u00e1vada","sequence":"additional","affiliation":[{"name":"Institute of Rheumatology, Prague, Czech Republic"},{"name":"Department of Rheumatology, Charles University First Faculty of Medicine, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Hor\u00e1k","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\u2014Nephrology, Rheumatology, Endocrinology, University Hospital Olomouc, Olomouc, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Bernardes","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Porto Faculty of Medicine, Porto, Portugal"},{"name":"Rheumatology Department, Centro Hospitalar e Universit\u00e1rio de S\u00e3o Jo\u00e3o, Porto, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsa","family":"Vieira-Sousa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, ULSSM, Instituto Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Centro Acad\u00e9mico de Medicina de Lisboa, Hospital de Santa Maria, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Castrej\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hospital General, Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Faculty of Medicine, Complutense University of Madrid, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Otero-Varela","sequence":"additional","affiliation":[{"name":"Research Unit, Spanish Society of Rheumatology, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalin","family":"Codreanu","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Disease, University of Medicine and Pharmacy, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Kuusalo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Division of Medicine, Turku University Hospital, Turku, Finland"},{"name":"Department of Internal Medicine, University of Turku, Turku, Finland"},{"name":"Rheumatology, Department of Medicine, Satakunta Central Hospital, Rauma, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vappu","family":"Rantalaiho","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, Tampere University Hospital, Tampere, Finland"},{"name":"Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland"},{"name":"Department of Medicine, Kanta-H\u00e4me Central Hospital, H\u00e4meenlinna, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-4049","authenticated-orcid":false,"given":"Anne C","family":"Regierer","sequence":"additional","affiliation":[{"name":"Epidemiology, German Rheumatology Research Center, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-0772","authenticated-orcid":false,"given":"Andreas","family":"Reich","sequence":"additional","affiliation":[{"name":"Epidemiology, German Rheumatology Research Center, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8769-6167","authenticated-orcid":false,"given":"Burkhard","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"Department Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8918-7304","authenticated-orcid":false,"given":"Raphael","family":"Micheroli","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Mielnik","sequence":"additional","affiliation":[{"name":"Section for Rheumatology, Department for Neurology, Rheumatology and Physical Medicine, Helse F\u00f8rde, Forde, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5442-902X","authenticated-orcid":false,"given":"Sella Aarrestad","family":"Provan","sequence":"additional","affiliation":[{"name":"Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway"},{"name":"Public Health Section, University of Inland Norway, Elverum, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Lass","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital Zurich, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Vorobjov","sequence":"additional","affiliation":[{"name":"Section for Rheumatology, Department for Neurology, Rheumatology and Physical Medicine, Helse F\u00f8rde, Forde, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-9189","authenticated-orcid":false,"given":"Ziga","family":"Rotar","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja Perdan","family":"Pirkmajer","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia"},{"name":"Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0474-5344","authenticated-orcid":false,"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[{"name":"Rheumatology Unit\u2014Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Conti","sequence":"additional","affiliation":[{"name":"Rheumatology, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza, University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4631-6505","authenticated-orcid":false,"given":"Bjorn","family":"Gudbjornsson","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology Research, Landsp\u00edtali\u2014The National University Hospital of Iceland, Reykjav\u00edk, Iceland"},{"name":"Faculty of Medicine, University of Iceland, Reykjav\u00edk, Iceland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3817-8288","authenticated-orcid":false,"given":"Daniela","family":"Di Giuseppe","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0966-878X","authenticated-orcid":false,"given":"Marleen","family":"van de Sande","sequence":"additional","affiliation":[{"name":"Department of Rheumatology & Clinical Immunology and Department of Experimental Immunology, Amsterdam Institute for Immunology & Infectious Diseases, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"Amsterdam Rheumatology and Immunology Center, Reade and Amsterdam UMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-3314","authenticated-orcid":false,"given":"Gary J","family":"Macfarlane","sequence":"additional","affiliation":[{"name":"Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Handan","family":"Yarkan-Tu\u011fsal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8931-8482","authenticated-orcid":false,"given":"Bente","family":"Glintborg","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4229-6818","authenticated-orcid":false,"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[{"name":"Copenhagen Center for Arthritis Research (COPECARE), Rigshospitalet Center for Rheumatology and Spine Diseases, Glostrup, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"2026050708151332000_12.2.e006477.1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(20)30800-X","article-title":"Psoriatic arthritis: still room for improvement","volume":"395","author":"Hetland","year":"2020","journal-title":"Lancet"},{"key":"2026050708151332000_12.2.e006477.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00874-5"},{"key":"2026050708151332000_12.2.e006477.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04775-2"},{"key":"2026050708151332000_12.2.e006477.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201194"},{"key":"2026050708151332000_12.2.e006477.5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169404"},{"key":"2026050708151332000_12.2.e006477.6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.970371","article-title":"The cardiometabolic conditions of psoriatic disease","volume":"13","author":"Toussirot","year":"2022","journal-title":"Front Immunol"},{"key":"2026050708151332000_12.2.e006477.7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41584-025-01326-6","article-title":"The obesity-inflammation axis in psoriatic disease: mechanisms and therapeutic strategies","volume":"22","author":"Haberman","year":"2026","journal-title":"Nat Rev Rheumatol"},{"key":"2026050708151332000_12.2.e006477.8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209775"},{"key":"2026050708151332000_12.2.e006477.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00798-0"},{"key":"2026050708151332000_12.2.e006477.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-225531"},{"key":"2026050708151332000_12.2.e006477.11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ard.2025.10.002","article-title":"EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis","volume":"85","author":"Marzo-Ortega","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"2026050708151332000_12.2.e006477.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195123","article-title":"Obesity and response to anti-tumor necrosis factor-\u03b1 agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis","volume":"13","author":"Singh","year":"2018","journal-title":"PLoS ONE"},{"key":"2026050708151332000_12.2.e006477.13","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/rheumatology\/kew326","article-title":"The influence of obesity on response to tumour necrosis factor-\u03b1 inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries","volume":"55","author":"H\u00f8jgaard","year":"2016","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2026050708151332000_12.2.e006477.14","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1093\/rheumatology\/keaa780","article-title":"Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort study","volume":"60","author":"Ballegaard","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2026050708151332000_12.2.e006477.15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/acr.23333","article-title":"Impact of Comorbidities on Tumor Necrosis Factor Inhibitor Therapy in Psoriatic Arthritis: A Population\u2010Based Cohort Study","volume":"70","author":"Ballegaard","year":"2018","journal-title":"Arthritis Care &Amp; Research"},{"key":"2026050708151332000_12.2.e006477.16","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13013","article-title":"Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings","volume":"48","author":"Iannone","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"2026050708151332000_12.2.e006477.17","doi-asserted-by":"crossref","DOI":"10.1186\/ar2670","article-title":"Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register","volume":"11","author":"Saad","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2026050708151332000_12.2.e006477.18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez427"},{"key":"2026050708151332000_12.2.e006477.19","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-023-03184-7"},{"key":"2026050708151332000_12.2.e006477.20","doi-asserted-by":"crossref","unstructured":"Ahmadzay ZF , Heberg J , J\u00f8rgensen JB , et al . Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey. Rheumatology Advances in Practice 2024;8. doi:10.1093\/rap\/rkae135","DOI":"10.1093\/rap\/rkae135"},{"key":"2026050708151332000_12.2.e006477.21","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199920020-00002"},{"key":"2026050708151332000_12.2.e006477.22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00393-019-0613-z","article-title":"RABBIT-SpA: a new disease register for axial spondyloarthritis and psoriatic arthritis","volume":"79","author":"Regierer","year":"2020","journal-title":"Z Rheumatol Germany"},{"key":"2026050708151332000_12.2.e006477.23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213463"},{"key":"2026050708151332000_12.2.e006477.24","unstructured":"European Union . Purchasing power adjusted GDP per capita. Available: https:\/\/doi.org\/10.2908\/SDG_10_10 [Accessed 25 Mar 2026]."},{"key":"2026050708151332000_12.2.e006477.25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement","volume":"18","author":"von Elm","year":"2007","journal-title":"Epidemiology (Sunnyvale)"},{"key":"2026050708151332000_12.2.e006477.26","doi-asserted-by":"crossref","unstructured":"Petersen MB , Hansen RL , Egeberg A , et al . The impact of comorbidities on interleukin-17 inhibitor therapy in psoriatic arthritis: a Danish population-based cohort study. Rheumatol Adv Pract 2023;7. doi:10.1093\/rap\/rkad035","DOI":"10.1093\/rap\/rkad035"},{"key":"2026050708151332000_12.2.e006477.27","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140021"},{"key":"2026050708151332000_12.2.e006477.28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/annrheumdis-2018-eular.1403","article-title":"THU0324\u2005Disease activity and patient characteristics by comorbidity among psoriatic arthritis (PSA) patients in a us registry","volume":"77","author":"Mease","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026050708151332000_12.2.e006477.29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ard.2025.01.020","article-title":"Do newly approved drugs have a worse observed safety profile than once established? A study on time trends in risks of key safety outcomes with immunomodulatory drugs against rheumatoid arthritis","volume":"84","author":"Molander","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026050708151332000_12.2.e006477.30","doi-asserted-by":"publisher","DOI":"10.1186\/S13075-018-1631-Y\/FIGURES\/6"},{"key":"2026050708151332000_12.2.e006477.31","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.625787"},{"key":"2026050708151332000_12.2.e006477.32","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaad.2024.12.025","article-title":"Risk of major adverse cardiovascular events and venous thromboembolic events between patients with psoriasis or psoriatic arthritis on tumor necrosis factor inhibitors, interleukin 17 inhibitors, interleukin 12\/23 inhibitors, and interleukin 23 inhibitors: An emulated target trial analysis","volume":"92","author":"Chen","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"2026050708151332000_12.2.e006477.33","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.190729"},{"key":"2026050708151332000_12.2.e006477.34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202325"},{"key":"2026050708151332000_12.2.e006477.35","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jamadermatol.2020.2977","article-title":"Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti-Interleukin 12\/23p40 Antibody Ustekinumab","volume":"156","author":"Poizeau","year":"2020","journal-title":"JAMA Dermatol"},{"key":"2026050708151332000_12.2.e006477.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109927"},{"key":"2026050708151332000_12.2.e006477.37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205675"},{"key":"2026050708151332000_12.2.e006477.38","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000077913.60364.D2"},{"key":"2026050708151332000_12.2.e006477.39","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X16673786"},{"key":"2026050708151332000_12.2.e006477.40","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2023.100706","article-title":"Differences and similarities between the EULAR\/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe","volume":"33","author":"Michelsen","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"2026050708151332000_12.2.e006477.41","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/rheumatology\/kev030","article-title":"Content and construct validity of the Rheumatic Diseases Comorbidity Index in patients with gout","volume":"54","author":"Spaetgens","year":"2015","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2026050708151332000_12.2.e006477.42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/kex387","article-title":"Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis","volume":"57","author":"Stober","year":"2018","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2026050708151332000_12.2.e006477.43","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171034"},{"key":"2026050708151332000_12.2.e006477.44","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.625787"},{"key":"2026050708151332000_12.2.e006477.45","first-page":"69","article-title":"The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort","volume":"42","author":"Ruscitti","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"2026050708151332000_12.2.e006477.46","doi-asserted-by":"publisher","DOI":"10.1038\/nature05485"},{"key":"2026050708151332000_12.2.e006477.47","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.815881","article-title":"Association of Gender, Diagnosis, and Obesity With Retention Rate of Secukinumab in Spondyloarthropathies: Results Form a Multicenter Real-World Study","volume":"8","author":"Garc\u00eda-Dorta","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026050708151332000_12.2.e006477.48","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001888"},{"key":"2026050708151332000_12.2.e006477.49","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1159\/000522008","article-title":"Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study","volume":"238","author":"Ortolan","year":"2022","journal-title":"Dermatology (Basel)"},{"key":"2026050708151332000_12.2.e006477.50","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2020-217251","article-title":"Secukinumab efficacy in patients with PsA is not dependent on patients\u2019 body mass index","volume":"81","author":"Pantano","year":"2022","journal-title":"Ann Rheum Dis"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2025-006477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:15:26Z","timestamp":1778166926000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2025-006477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,5,7]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1136\/rmdopen-2025-006477"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2025-006477","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]}}}